The Glutamate-Serine-Glycine Index as a Biomarker to Monitor the Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease
The GSG index can potentially be developed as a marker for monitoring the response of patients with NAFLD to bariatric surgery.
Authors
- Jean‐Paul Kovalik (ORCID: https://orcid.org/0000-0003-3654-8193)
- George Boon‐Bee Goh (ORCID: https://orcid.org/0000-0001-8221-5299)
- Elizabeth Shumbayawonda (ORCID: https://orcid.org/0000-0003-0351-2063)
- Weng Hoong Chan (ORCID: https://orcid.org/0000-0002-7361-7525)
- Phong Ching Lee (ORCID: https://orcid.org/0000-0002-9446-2032)
- Yong Mong Bee (ORCID: https://orcid.org/0000-0002-5482-2646)
- Jianhong Ching (ORCID: https://orcid.org/0000-0003-1526-8459)
- Pik‐Eu Chang (ORCID: https://orcid.org/0000-0002-2702-8412)
- Hong Chang Tan
- Kee Voon Chua (ORCID: https://orcid.org/0000-0001-8702-8230)
- Lionel Tim‐Ee Cheng (ORCID: https://orcid.org/0000-0002-1068-7868)
- Nichole Yue Ting Tan (ORCID: https://orcid.org/0009-0002-3232-9233)
- Sharon Hong Yu Han
- Chin Hong Lim (ORCID: https://orcid.org/0000-0001-5581-048X)
- Albert Su Chong Low
- Mei Fang Tay
- Alvin Eng (ORCID: https://orcid.org/0009-0007-0146-7496)
Institutions
- Singapore General Hospital (SG)
- British Society of Periodontology (GB)
- Duke-NUS Medical School (SG)
Publication Details
- Journal
- Journal of the ASEAN Federation of Endocrine Societies
- Published
- 2024-09-13
- DOI
- https://doi.org/10.15605/jafes.039.02.20
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77